Ergomed expands operations in Japan PRESS RELEASE Ergomed expands operations in Japan New legal entity and regional office established in Tokyo responding to client demand Guildford, UK – 26 April 2021: Ergomed plc (LSE: ERGO)...

Ergomed acquires MedSource, a US-based specialist oncology and rare disease CRO PRESS RELEASE Ergomed acquires MedSource, a US-based specialist oncology and rare disease CRO Further expansion of Ergomed’s presence in the strategically important US market MedSource’s...

Ergomed Enters Strategic Collaboration to Drive Pharmacovigilance Leadership in Intelligent Automation RNS REACHPRESS RELEASE Ergomed Enters Strategic Collaboration to Drive Pharmacovigilance Leadership in Intelligent Automation PrimeVigilance collaboration with Automation Anywhere and DataRobot to...

Acquisition of Ashfield Pharmacovigilance Inc., a US pharmacovigilance services provider, from UDG Healthcare for $10 million  PRESS RELEASE Acquisition of Ashfield Pharmacovigilance Inc., a US pharmacovigilance services provider, from UDG Healthcare for $10 million Ashfield Pharmacovigilance Inc. becomes part of Ergomed’s...